InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by HAMILTON JOHN F, Director. Director active across 1 company, notably Aridis Pharmaceuticals, Inc.. In total, 3 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €16k. History available since 27 July 2021. The latest transaction was disclosed on 27 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
John F. Hamilton is a Board Member at Aridis Pharmaceuticals, Inc. He brings his expertise in corporate governance and strategy to the management team. Hamilton is involved in key decisions regarding product development and the strategic direction of the company. His experience in the pharmaceutical sector is a valuable asset for Aridis.